Literature DB >> 22581968

A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11β gene.

Merel S Ebberink1, Janet Koster, Gepke Visser, Francjan van Spronsen, Irene Stolte-Dijkstra, G Peter A Smit, Johanna M Fock, Stephan Kemp, Ronald J A Wanders, Hans R Waterham.   

Abstract

BACKGROUND: Peroxisomes are organelles that proliferate continuously and play an indispensable role in human metabolism. Consequently, peroxisomal gene defects can cause multiple, often severe disorders, including the peroxisome biogenesis disorders. Currently, 13 different PEX proteins have been implicated in various stages of peroxisome assembly and protein import. Defects in any of these proteins result in a peroxisome biogenesis disorder. The authors present here a novel genetic defect specifically affecting the division of peroxisomes.
METHODS: The authors have studied biochemical and microscopical peroxisomal parameters in cultured patient fibroblasts, sequenced candidate PEX genes and determined the consequence of the identified PEX11β gene defect on peroxisome biogenesis in patient fibroblasts at different temperatures.
RESULTS: The patient presented with congenital cataracts, mild intellectual disability, progressive hearing loss, sensory nerve involvement, gastrointestinal problems and recurrent migraine-like episodes. Although microscopical investigations of patient fibroblasts indicated a clear defect in peroxisome division, all biochemical parameters commonly used for diagnosing peroxisomal disorders were normal. After excluding mutations in all PEX genes previously implicated in peroxisome biogenesis disorders, it was found that the defect was caused by a homozygous non-sense mutation in the PEX11β gene. The peroxisome division defect was exacerbated when the patient's fibroblasts were cultured at 40°C, which correlated with a marked decrease in the expression of PEX11γ.
CONCLUSIONS: This novel isolated defect in peroxisome division expands the clinical and genetic spectrum of peroxisomal disorders and indicates that peroxisomal defects exist, which cannot be diagnosed by standard laboratory investigations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581968     DOI: 10.1136/jmedgenet-2012-100778

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  51 in total

Review 1.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

2.  BAK regulates catalase release from peroxisomes.

Authors:  Yukio Fujiki; Non Miyata; Satoru Mukai; Kanji Okumoto; Emily H Cheng
Journal:  Mol Cell Oncol       Date:  2017-03-17

3.  Coupling organelle inheritance with mitosis to balance growth and differentiation.

Authors:  Amma Asare; John Levorse; Elaine Fuchs
Journal:  Science       Date:  2017-02-03       Impact factor: 47.728

4.  The membrane remodeling protein Pex11p activates the GTPase Dnm1p during peroxisomal fission.

Authors:  Chris Williams; Lukasz Opalinski; Christiane Landgraf; Joseph Costello; Michael Schrader; Arjen M Krikken; Kèvin Knoops; Anita M Kram; Rudolf Volkmer; Ida J van der Klei
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

5.  Clinical utility gene card for: Zellweger syndrome spectrum.

Authors:  Hendrik Rosewich; Hans Waterham; Bwee Tien Poll-The; Andreas Ohlenbusch; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2014-11-19       Impact factor: 4.246

6.  Postfixation detergent treatment liberates the membrane modelling protein Pex11β from peroxisomal membranes.

Authors:  Michael Schrader; Monica Almeida; Sandra Grille
Journal:  Histochem Cell Biol       Date:  2012-08-09       Impact factor: 4.304

7.  The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.

Authors:  Shandi Hiebler; Tomohiro Masuda; Joseph G Hacia; Ann B Moser; Phyllis L Faust; Anita Liu; Nivedita Chowdhury; Ning Huang; Amanda Lauer; Jean Bennett; Paul A Watkins; Donald J Zack; Nancy E Braverman; Gerald V Raymond; Steven J Steinberg
Journal:  Mol Genet Metab       Date:  2014-01-23       Impact factor: 4.797

8.  Novel PEX3 Gene Mutations Resulting in a Moderate Zellweger Spectrum Disorder.

Authors:  C Maxit; I Denzler; D Marchione; G Agosta; J Koster; R J A Wanders; S Ferdinandusse; H R Waterham
Journal:  JIMD Rep       Date:  2016-08-25

Review 9.  Peroxisomes take shape.

Authors:  Jennifer J Smith; John D Aitchison
Journal:  Nat Rev Mol Cell Biol       Date:  2013-12       Impact factor: 94.444

10.  Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios.

Authors:  Katharina Herzog; Mia L Pras-Raves; Martin A T Vervaart; Angela C M Luyf; Antoine H C van Kampen; Ronald J A Wanders; Hans R Waterham; Frédéric M Vaz
Journal:  J Lipid Res       Date:  2016-06-09       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.